Summit Creek Advisors LLC Increases Stake in Omnicell, by 20.6% in 4th Quarter
May 19, 2023
Trending News 🌥️
Summit Creek Advisors LLC recently reported an increase in their stake in Omnicell ($NASDAQ:OMCL), Inc. by 20.6% in the fourth quarter. Omnicell is a leader in medication and supply management technology solutions that are used by healthcare providers to increase operational and clinical efficiency. The company is dedicated to helping healthcare professionals improve patient care by providing systems that enable them to manage, control and automate the distribution of medications and medical supplies. Omnicell also develops analytics solutions to help healthcare organizations measure, monitor and improve operational performance. Their technology solutions enable healthcare providers to keep up with the ever-changing demands of the industry, while also streamlining their operations.
In addition, Omnicell offers a variety of services designed to provide customers with an enhanced level of support. Summit Creek Advisors LLC’s increased stake in Omnicell provides evidence of their trust in the company and its products. As a leader in medication and supply management technology, Omnicell is well-positioned to continue to provide value to healthcare providers throughout the industry.
Analysis
GoodWhale recently conducted an analysis of OMNICELL‘s wellbeing. Our Risk Rating of the company indicated that OMNICELL is a high risk investment, both from a financial and business perspective. Upon further investigation, we have detected four risk warnings in the income sheet, balance sheet, cashflow statement, and non-financial areas respectively. If you are interested in learning more about these risks, please become a registered user on our platform and check it out. More…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Omnicell. More…
| Total Revenues | Net Income | Net Margin |
| 1.27k | -17.57 | -1.4% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Omnicell. More…
| Operations | Investing | Financing |
| 106.55 | -53.58 | 15.03 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Omnicell. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 2.25k | 1.11k | 25.08 |
Key Ratios Snapshot
Some of the financial key ratios for Omnicell are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 11.1% | 26.3% | -2.4% |
| FCF Margin | ROE | ROA |
| 3.7% | -1.7% | -0.8% |
Peers
The company’s products are used by hospitals, nursing homes, home health agencies, and other healthcare providers. Omnicell Inc’s competitors include Nexus AG, PrimeCare Systems Inc, 10x Genomics Inc, and other companies that provide similar products and services.
– Nexus AG ($LTS:0FGL)
Nexus AG is a German software company that specializes in enterprise resource planning (ERP) software. The company has a market capitalization of 814.29 million euros as of 2022 and a return on equity of 11.21%. Nexus AG’s main competitors include SAP SE, Oracle Corporation, and Microsoft Corporation.
– PrimeCare Systems Inc ($OTCPK:PCYS)
PrimaCare Systems Inc is a publicly traded company with a market capitalization of $44.19 million as of March 2022. The company has a return on equity of 9.24%. PrimaCare Systems Inc is a healthcare technology company that provides software and services to healthcare providers.
– 10x Genomics Inc ($NASDAQ:TXG)
10x Genomics Inc is a life sciences company that develops and sells products and services for genomic analysis. The company’s products include sequencing services, software, and tools for analyzing genomic data. 10x Genomics was founded in 2012 and is headquartered in Pleasanton, California.
10x Genomics has a market cap of $3.07 billion as of 2022 and a return on equity of -10.81%. The company’s products are used for genomic sequencing and analysis, and its services include software and tools for analyzing genomic data. 10x Genomics was founded in 2012 and is headquartered in Pleasanton, California.
Summary
Omnicell, Inc. is an attractive investment opportunity for investors looking for potential growth. The company provides medication and supply management solutions that help healthcare facilities improve operational efficiency, reduce costs, increase patient safety, and enhance clinical outcomes. Having experienced steady growth since its inception, Omnicell’s stock has proven to be resilient in the face of market volatility. With its competitive edge, experienced leadership, and innovative solutions, the company looks set to continue performing well into the future.
Related Posts
Recent Posts
